SIX2 and breast carcinoma: Table 1 shows the characteristics of all 20 studies.[27–46] These studies mainly assessed the association between the mRNA expression of SIX1, SIX2, SIX3, SIX4, SIX5, and SIX6 with clinical parameters of breast cancer.